Midwest Chest Consultants

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• COPD4 trials

Phase

• Phase 22 trials
• Phase 32 trials

Status

• Active, not recruiting2 trials
• Completed2 trials

Lead sponsor

• Genentech, Inc.1 trial
• Hoffmann-La Roche1 trial
• Uniquity One (UNI)1 trial
• Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA1 trial

Running trials

• Active, not recruiting

  A Study to Evaluate Solrikitug in Participants With COPD (ZION)

  NCT06496620· Phase 2· Uniquity One (UNI)· Source

• Active, not recruiting

  A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)

  NCT05878769· Phase 3· Hoffmann-La Roche· Source

Closed trials

• Completed

  Effect of Ensifentrine Treatment on CAT Score

  NCT06460493· Phase 3· Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA· Source

• Completed

  A Study to Evaluate the Efficacy and Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease

  NCT05037929· Phase 2· Genentech, Inc.· Source